Neok Bio, Inc.
Clinical trials sponsored by Neok Bio, Inc., explained in plain language.
-
New drug aims to shrink hard-to-treat tumors
Disease control Recruiting nowThis study tests an experimental drug called NEOK002 in people with advanced solid tumors that have spread and cannot be removed by surgery. The drug is designed to target two proteins on cancer cells to deliver a toxic payload. The study has two parts: first, finding the safest …
Phase: PHASE1 • Sponsor: NEOK Bio, Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
New drug NEOK001 targets Hard-to-Treat cancers in first human trial
Disease control Recruiting nowThis early-phase trial tests a new drug called NEOK001 in people with advanced solid tumors that have stopped responding to standard treatments. NEOK001 is designed to deliver a cancer-killing agent directly to tumor cells by targeting two specific proteins. The study will first …
Phase: PHASE1 • Sponsor: NEOK Bio, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC